188 related articles for article (PubMed ID: 34024504)
1. N-3 fatty acid EPA supplementation in cancer patients receiving abdominal radiotherapy - A randomised controlled trial.
Patursson P; Møller G; Muhic A; Andersen JR
Clin Nutr ESPEN; 2021 Jun; 43():130-136. PubMed ID: 34024504
[TBL] [Abstract][Full Text] [Related]
2. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
[TBL] [Abstract][Full Text] [Related]
3. Fish oil supplementation in cancer patients. Capsules or nutritional drink supplements? A controlled study of compliance.
Schmidt N; Møller G; Bæksgaard L; Østerlind K; Stark KD; Lauritzen L; Andersen JR
Clin Nutr ESPEN; 2020 Feb; 35():63-68. PubMed ID: 31987122
[TBL] [Abstract][Full Text] [Related]
4. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
5. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.
Werner K; Küllenberg de Gaudry D; Taylor LA; Keck T; Unger C; Hopt UT; Massing U
Lipids Health Dis; 2017 Jun; 16(1):104. PubMed ID: 28578704
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
8. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Omega-3 Enriched Oral Nutrition Supplement on Nutritional Indices and Quality of Life in Gastrointestinal Cancer Patients: A Randomized Clinical Trial.
Sim E; Kim JM; Lee SM; Chung MJ; Song SY; Kim ES; Chun HJ; Sung MK
Asian Pac J Cancer Prev; 2022 Feb; 23(2):485-494. PubMed ID: 35225460
[TBL] [Abstract][Full Text] [Related]
11. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review.
Elia M; Van Bokhorst-de van der Schueren MA; Garvey J; Goedhart A; Lundholm K; Nitenberg G; Stratton RJ
Int J Oncol; 2006 Jan; 28(1):5-23. PubMed ID: 16327975
[TBL] [Abstract][Full Text] [Related]
12. Oral nutritional supplements in a randomised trial are more effective than dietary advice at improving quality of life in malnourished care home residents.
Parsons EL; Stratton RJ; Cawood AL; Smith TR; Elia M
Clin Nutr; 2017 Feb; 36(1):134-142. PubMed ID: 26847947
[TBL] [Abstract][Full Text] [Related]
13. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
McDaniel JC; Rausch J; Tan A
Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic and docosahexaenoic acids-rich fish oil supplementation attenuates strength loss and limited joint range of motion after eccentric contractions: a randomized, double-blind, placebo-controlled, parallel-group trial.
Tsuchiya Y; Yanagimoto K; Nakazato K; Hayamizu K; Ochi E
Eur J Appl Physiol; 2016 Jun; 116(6):1179-88. PubMed ID: 27085996
[TBL] [Abstract][Full Text] [Related]
15. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.
van der Meij BS; Langius JA; Smit EF; Spreeuwenberg MD; von Blomberg BM; Heijboer AC; Paul MA; van Leeuwen PA
J Nutr; 2010 Oct; 140(10):1774-80. PubMed ID: 20739445
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
17. Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial.
Chagas TR; Borges DS; de Oliveira PF; Mocellin MC; Barbosa AM; Camargo CQ; Del Moral JÂG; Poli A; Calder PC; Trindade EBSM; Nunes EA
J Hum Nutr Diet; 2017 Dec; 30(6):681-692. PubMed ID: 28374923
[TBL] [Abstract][Full Text] [Related]
18. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
19. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
